Mechanism and efficacy of sub-50 nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma

Lignende værker

• Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation
  af: Trembley, Janeen H., et al.
  Udgivet: (2014)
• CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors
  af: Ahmed, Khalil, et al.
  Udgivet: (2016)
• Tenfibgen Ligand Nanoencapsulation Delivers Bi-Functional Anti-CK2 RNAi Oligomer to Key Sites for Prostate Cancer Targeting Using Human Xenograft Tumors in Mice
  af: Trembley, Janeen H., et al.
  Udgivet: (2014)
• CK2 Molecular Targeting—Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer
  af: Trembley, Janeen H., et al.
  Udgivet: (2017)
• Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells
  af: Trembley, Janeen H., et al.
  Udgivet: (2011)